PERSPECTA

News from every angle

← Back to headlines

AbbVie and Genmab Announce Lymphoma Therapy Trial Setback

Pharmaceutical companies AbbVie and Genmab have announced a setback in a late-stage clinical trial for their lymphoma therapy. This development could impact the future availability and development of the treatment.

24 Jul, 11:54 — 24 Jul, 11:54
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed24d ago

AbbVie, Genmab announce late-stage trial setback for lymphoma therapy

Read full article →

Related Stories

Men Seek Penile Fillers Despite Health Risks

1h ago

Airline Pilots Face Highest Cancer Risk from Radiation Exposure

2h ago

Study Reveals Elderly More Vulnerable to Extreme Heat Than Previously Thought

5h ago

Nollywood Actor Ogogo Hassan's Daughters Seek Help for Father's Stage 4 Cancer

9h ago